Earnings Feed
Sign Up
Home/Filings/4/0001181431-12-040448
4//SEC Filing

Riehle J Nick 4

Accession 0001181431-12-040448

CIK 0001333763other
View on SEC.govCompany Profile

Filed

Jul 10, 8:00 PM ET

Accepted

Jul 11, 5:57 PM ET

Size

16.4 KB

Accession

0001181431-12-040448

Insider Transaction Report

Form 4
Period: 2012-07-09
Chelsea Therapeutics International, Ltd.CHTP
Riehle J Nick
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2012-07-09+50,000→ 50,000 total
    Exercise: $1.24Exp: 2022-07-09→ Common Stock (50,000 underlying)
Holdings

  • Stock Option (Right to Buy)

    Exercise: $4.54Exp: 2022-01-25→ Common Stock (50,000 underlying)
    50,000

  • Common Stock

    66,183

  • Stock Option (Right to Buy)

    Exercise: $2.62Exp: 2015-01-10→ Common Stock (68,923 underlying)
    68,923
Footnotes (9)
  • [F1]Option vests in four equal annual installments beginning on July 9, 2013.
  • [F2]Option vests in four equal annual installments beginning on January 25, 2013.
  • [F3]Option vests in four equal annual installments beginning on January 11, 2012.
  • [F4]Option vests in four equal annual installments beginning on January 19, 2011.
  • [F5]Option vests in four equal annual installments beginning on January 22, 2010.
  • [F6]Option vests in four equal annual installments beginning on January 24, 2009.
  • [F7]Option vested in four equal annual installments beginning on February 6, 2008.
  • [F8]Option vested in four equal installments beginning on January 19, 2007.
  • [F9]Option vested in four equal annual installments beginning on January 10, 2006.

Documents

1 file

Issuer

Chelsea Therapeutics International, Ltd.

CIK 0001333763

→
Entity typeother

Related Parties

1
  • filerCIK 0001316746

Filing Metadata

Form type
4
Filed
Jul 10, 8:00 PM ET
Accepted
Jul 11, 5:57 PM ET
Size
16.4 KB
View on SEC.gov